(0.27%) 5 113.83 points
(0.23%) 38 328 points
(0.24%) 15 967 points
(-0.49%) $83.44
(2.65%) $1.974
(-0.16%) $2 343.40
(-0.12%) $27.50
(2.80%) $947.95
(-0.03%) $0.934
(-0.10%) $11.01
(-0.24%) $0.798
(0.79%) $92.60
@ $14.75
发出时间: 15 Feb 2024 @ 02:48
回报率: -29.63%
上一信号: Feb 15 - 00:25
上一信号:
回报率: 0.20 %
Live Chart Being Loaded With Signals
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes...
Stats | |
---|---|
今日成交量 | 16 616.00 |
平均成交量 | 432 548 |
市值 | 597.67M |
EPS | $0.590 ( 2024-02-09 ) |
下一个收益日期 | ( $0.430 ) 2024-05-10 |
Last Dividend | $0.150 ( 2023-12-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | 10.81 |
ATR14 | $0.0110 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-04-01 | Reidy Christopher R | Sell | 0 | Common Stock |
2022-04-01 | Melcher David F | Sell | 0 | Common Stock |
2024-04-04 | Kurdikar Devdatt | Sell | 4 535 | Common Stock |
2024-02-11 | Kurdikar Devdatt | Sell | 17 165 | Common Stock |
2024-02-12 | Melcher David F | Buy | 2 000 | Common Stock |
INSIDER POWER |
---|
77.58 |
Last 100 transactions |
Buy: 2 135 787 | Sell: 79 609 |
音量 相关性
Embecta Corp. 相关性 - 货币/商品
Embecta Corp. 财务报表
Annual | 2023 |
营收: | $1.12B |
毛利润: | $749.90M (66.91 %) |
EPS: | $1.230 |
FY | 2023 |
营收: | $1.12B |
毛利润: | $749.90M (66.91 %) |
EPS: | $1.230 |
FY | 2022 |
营收: | $1.13B |
毛利润: | $774.90M (68.61 %) |
EPS: | $3.92 |
FY | 2021 |
营收: | $1.17B |
毛利润: | $800.00M (68.67 %) |
EPS: | $7.28 |
Financial Reports:
No articles found.
Embecta Corp. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.150 (N/A) |
$0.150 (N/A) |
$0.150 (N/A) |
$0.150 (N/A) |
$0.150 (N/A) |
$0.150 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.150 | 2022-08-25 |
Last Dividend | $0.150 | 2023-12-01 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | $0.900 | -- |
Avg. Dividend % Per Year | 0.90% | -- |
Score | 2.81 | -- |
Div. Sustainability Score | 4.97 | |
Div.Growth Potential Score | 0.974 | |
Div. Directional Score | 2.97 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $0.300 | 0.64% |
2023 | $0.600 | 2.37% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0493 | 1.500 | 9.01 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0454 | 1.200 | 8.49 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.0681 | 1.500 | -1.868 | -2.80 | [0.1 - 1] |
payoutRatioTTM | 0.778 | -1.000 | 2.22 | -2.22 | [0 - 1] |
currentRatioTTM | 2.20 | 0.800 | 3.99 | 3.19 | [1 - 3] |
quickRatioTTM | 1.547 | 0.800 | 5.61 | 4.49 | [0.8 - 2.5] |
cashRatioTTM | 0.915 | 1.500 | 6.03 | 9.05 | [0.2 - 2] |
debtRatioTTM | 1.344 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 1.633 | 1.000 | -0.506 | -0.506 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.101 | 2.00 | -0.0336 | -0.0673 | [0 - 30] |
freeCashFlowPerShareTTM | -0.527 | 2.00 | -0.264 | -0.527 | [0 - 20] |
debtEquityRatioTTM | -2.06 | -1.500 | -8.25 | 10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.666 | 1.000 | 2.24 | 2.24 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.159 | 1.000 | 8.82 | 8.82 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.00354 | 1.000 | -1.131 | -1.131 | [0.2 - 2] |
assetTurnoverTTM | 0.922 | 0.800 | 7.19 | 5.75 | [0.5 - 2] |
Total Score | 4.97 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.72 | 1.000 | 9.02 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0681 | 2.50 | -1.201 | -2.80 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.527 | 2.00 | -0.176 | -0.527 | [0 - 30] |
dividendYielPercentageTTM | 5.82 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.101 | 2.00 | -0.0336 | -0.0673 | [0 - 30] |
payoutRatioTTM | 0.778 | 1.500 | 2.22 | -2.22 | [0 - 1] |
pegRatioTTM | -0.156 | 1.500 | -4.37 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.00517 | 1.000 | -2.63 | 0 | [0.1 - 0.5] |
Total Score | 0.974 |
Embecta Corp.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。